Last edition
News about "Aurobindo Pharma to Increase Stake in China JV for"
Aurobindo Pharma to Increase Stake in China JV for USD 5.12 Million
Aurobindo Pharma has announced plans to increase its shareholding in its China-based joint venture, Luoxin Aurovitas Pharma (Chengdu), by 20 percent through a cash investment of USD 5.12 million.
Aurobindo Pharma To Increase Stake In China JV For | 26/12/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members